NGL Fine-Chem - Quaterly Results

22 May 2025 Evaluate
Revenue showed a marginal decline at Rs. 930.18 millions. For the quarter ended March 2025, as compared to corresponding quarter of last year.The Net Loss for the quarter ended March 2025 is Rs. -5.20 millions as compared to Net Profit of Rs. 108.50 millions of corresponding quarter ended March 2024Operating profit for the quarter ended March 2025 decreased to 31.19 millions as compared to 167.60 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 930.18 956.09 -2.71 3592.94 3289.73 9.22 3592.94 3289.73 9.22
Other Income -7.90 41.64 -118.97 97.58 159.01 -38.63 97.58 159.01 -38.63
PBIDT 31.19 167.60 -81.39 354.59 601.94 -41.09 354.59 601.94 -41.09
Interest 9.47 4.58 106.77 23.07 13.38 72.42 23.07 13.38 72.42
PBDT 21.72 163.02 -86.68 331.52 588.56 -43.67 331.52 588.56 -43.67
Depreciation 25.32 20.64 22.67 92.70 81.48 13.77 92.70 81.48 13.77
PBT -3.60 142.38 -102.53 238.82 507.08 -52.90 238.82 507.08 -52.90
TAX 1.60 33.88 -95.28 57.50 121.89 -52.83 57.50 121.89 -52.83
Deferred Tax 4.16 1.13 268.14 4.06 7.76 -47.68 4.06 7.76 -47.68
PAT -5.20 108.50 -104.79 181.32 385.19 -52.93 181.32 385.19 -52.93
Equity 30.89 30.89 0.00 30.89 30.89 0.00 30.89 30.89 0.00
PBIDTM(%) 3.35 17.53 -80.87 9.87 18.30 -46.06 9.87 18.30 -46.06

NGL Fine-Chem Share Price

1505.20 -20.80 (-1.36%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×